Recent progress in pancreatic cancer
- PMID: 23856911
- PMCID: PMC3769458
- DOI: 10.3322/caac.21190
Recent progress in pancreatic cancer
Abstract
Pancreatic cancer is currently one of the deadliest of the solid malignancies. However, surgery to resect neoplasms of the pancreas is safer and less invasive than ever, novel drug combinations have been shown to improve survival, advances in radiation therapy have resulted in less toxicity, and enormous strides have been made in the understanding of the fundamental genetics of pancreatic cancer. These advances provide hope but they also increase the complexity of caring for patients. It is clear that multidisciplinary care that provides comprehensive and coordinated evaluation and treatment is the most effective way to manage patients with pancreatic cancer.
Keywords: medical oncology; molecular biology; pancreatic neoplasms; radiation oncology; radiology.
Copyright © 2013 American Cancer Society, Inc.
Conflict of interest statement
Conflict of interest: Dr. Hruban receives royalty payments from Myriad Genetics for the PALB2 invention
Figures


















References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical